Tag: obesity
-
Wegovy Moves Closer to PBS Listing for Adults with Obesity and Heart Disease
What is Wegovy and why the PBS listing matters Semaglutide, marketed as Wegovy, is a prescription medication designed to help adults with obesity lose weight and improve related health risks. The latest development from the Pharmaceutical Benefits Advisory Committee (PBAC) signals a significant step toward adding Wegovy to the Pharmaceutical Benefits Scheme (PBS) for people…
-
Rural women-led community action key to tackling India’s metabolic diseases: Experts
Rural women at the forefront of India’s metabolic disease response Experts at a panel on public-private collaboration held at AIG Hospitals in Hyderabad highlighted an often overlooked force in India’s battle against obesity and metabolic diseases: rural women-led community action. The discussion underscored how village-level networks, women’s self-help groups, and local institutions can drive prevention,…
-
Wegovy Advances to PBS Listing: Semaglutide for Obesity and Heart Disease
Wegovy Moves Closer to PBS Listing Semaglutide, sold under the brand Wegovy, is nearing a pivotal milestone in Australia’s healthcare system. After preliminary recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC), Wegovy could soon be available on the Pharmaceutical Benefits Scheme (PBS) for adults with established cardiovascular disease who also have obesity. This potential PBS…
-
Rural Women Lead Community Action Against India’s Metabolic Diseases
Rural Women at the Forefront of India’s Metabolic Health Push India faces a growing burden of obesity and metabolic diseases, with rural communities often bearing the unseen brunt. A recent panel discussion at AIG Hospitals in Hyderabad highlighted how rural women and local community institutions are becoming pivotal drivers in the country’s response to this…
-
Wegovy Moves Closer to PBS Listing for Australians with Obesity and Heart Risk
What’s happening with Wegovy and the PBS The anti-obesity drug Wegovy, whose active ingredient is semaglutide, has taken a significant step toward being added to Australia’s Pharmaceutical Benefits Scheme (PBS). The move signals a potential change in how adults living with obesity and established cardiovascular disease could access a proven therapy at a reduced price,…
-
Rural Women Lead the Charge Against India’s Metabolic Diseases Through Community Action
Rural women emerge as pivotal drivers in India’s fight against metabolic diseases At a recent panel discussion on public private collaboration hosted by AIG Hospitals in Hyderabad, experts highlighted how rural women-led networks and grassroots community institutions are becoming essential components of India’s strategy to curb obesity and metabolic diseases. The session underscored the potential…
-
Tackling Unsustainable Food Systems for Health and Climate Gains
Why unsustainable food systems matter for health and the climate The latest synthesis in Frontiers in Science makes a compelling case that our changing food environment is more than a nutrition issue—it’s a planetary health crisis. The review highlights how unsustainable food systems contribute to rising obesity rates while exacerbating environmental harms such as greenhouse…
-
Tackling Unsustainable Food Systems for Health and Climate Benefits
Introduction: The double-edged challenge of our food environment Recent evidence summarized in a major Frontiers in Science review highlights a critical reality: our changing food environment is fueling both rising obesity and mounting environmental harms. Tackling unsustainable food systems is not just a health issue; it is a climate action imperative. By realigning what, how,…
-
Can the MIND Diet Help Obesity Management? A Swedish Trial Signals New Possibilities
Introduction: A Brain-Healthy Approach to Obesity Obesity management has long focused on calories and physical activity, but emerging research highlights the potential for dietary patterns that support brain health to influence weight, mood, and overall metabolic function. A new trial in Sweden is testing whether the MIND diet—already associated with cognitive benefits—can be realistically adopted…
-
MIND Diet Trial Could Redefine Obesity Management in Sweden
Introduction: A brain-healthy approach to obesity Researchers in Sweden are piloting a trial to determine whether the MIND diet—originally developed to protect cognitive function—can be scaled as an effective strategy for obesity management. The study sits at the intersection of nutrition, gut health, and mental well-being, aiming to see if a brain-focused dietary pattern can…